caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1881761872

NPI 1881761872

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where NPI 1881761872's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 21 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
THE GENERAL HOSPITAL CORPORATION6091,100
Jessica Fewkes
Dermatology · Boston, MA
3374
Mayra Lorenzo
Dermatology · Boston, MA
3267
Arthur Sober
Dermatology · Boston, MA
2959
Molly Yancovitz
Dermatology · Boston, MA
2971
Bonnie Mackool
Dermatology · Boston, MA
2042
HUGHES, ROBERT2032
Aliza Stern
Physician Assistant · Boston, MA
1919
Arianne Kourosh
Dermatology · Boston, MA
1732
Natalie Grevelink
Physician Assistant · Park City, UT
1717
Hensin Tsao
Dermatology · Boston, MA
1636
Quest Diagnostics Massachusetts Llc
Clinical Laboratory · Marlborough, MA
1628
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.